A mechanism based approach to management of children with end-stage liver disease

Allah B Haafiz1

  • 1a Pediatric Transplant Hepatology, Organ Transplant and Hepatobiliary Surgery , King Abdullah Specialized Children Hospital , Riyadh , KSA.

Insights

Optimizing pre-transplant care for children with end-stage liver disease (ESLD) is crucial for successful liver transplantation (LT). This review details management strategies for ESLD complications to improve pediatric LT outcomes.

Area of Science:

  • Pediatric Hepatology
  • Transplantation Medicine
  • Gastroenterology

Background:

  • Liver transplantation (LT) has significantly improved outcomes for children with end-stage liver disease (ESLD).
  • Pre-transplant management of ESLD complications remains a significant challenge despite advances in surgical and acute care.
  • Organ shortage and increasing survival expectations necessitate sophisticated pre-transplant strategies.

Purpose of the Study:

  • To provide mechanism-based management strategies for common ESLD complications in children.
  • To guide the formulation of pre-transplant management plans for pediatric liver transplantation.
  • To enhance outcomes of pediatric liver transplantation through optimized pre-transplant care.

Main Methods:

  • Review of current literature on ESLD management strategies.
  • Discussion of pathophysiologic mechanisms underlying ESLD complications.
  • Identification of high-impact therapeutic interventions for pre-transplant care.

Main Results:

  • Detailed strategies for managing malnutrition, altered metabolic pathways, gastrointestinal dysfunction, and ascites in pediatric ESLD.
  • Clinically relevant discussions linking mechanisms to therapeutic interventions.
  • A tabulated summary of suggested interventions for pre-transplant management.

Conclusions:

  • A dynamic, tailored pre-transplant management plan is essential for improving pediatric LT outcomes.
  • Sophisticated management of pre-transplant ESLD presents a major opportunity to enhance the future of pediatric LT.
  • Addressing ESLD complications proactively can significantly impact graft and patient survival post-transplantation.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
243
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
294
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
286
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
664
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
413
Liver Physiology01:30

Liver Physiology

The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
3.9K